ArticleDiabetes care2022

Serum Orotidine: A Novel Biomarker of Increased CVD Risk in Type 2 Diabetes Discovered Through Metabolomics Studies.

Hetal S Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.